These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33960103)

  • 1. Genotype-phenotype studies in a large cohort of Brazilian patients with Hunter syndrome.
    Josahkian JA; Brusius-Facchin AC; Netto ABO; Leistner-Segal S; Málaga DR; Burin MG; Michelin-Tirelli K; Trapp FB; Cardoso-Dos-Santos AC; Ribeiro EM; Kim CA; de Siqueira ACM; Santos ML; do Valle DA; da Silva RTB; Horovitz DDG; de Medeiros PFV; de Souza CFM; Giuliani LR; Miguel DSCG; Santana-da-Silva LC; Galera MF; Giugliani R
    Am J Med Genet C Semin Med Genet; 2021 Sep; 187(3):349-356. PubMed ID: 33960103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular diagnosis of 65 families with mucopolysaccharidosis type II (Hunter syndrome) characterized by 16 novel mutations in the IDS gene: Genetic, pathological, and structural studies on iduronate-2-sulfatase.
    Kosuga M; Mashima R; Hirakiyama A; Fuji N; Kumagai T; Seo JH; Nikaido M; Saito S; Ohno K; Sakuraba H; Okuyama T
    Mol Genet Metab; 2016 Jul; 118(3):190-197. PubMed ID: 27246110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive and adaptive behaviors associated with disease severity and genotype in patients with mucopolysaccharidosis II.
    Yee KS; Alexanderian D; Merberg D; Natarajan M; Wang S; Wu Y; Whiteman DAH
    Mol Genet Metab; 2023 Nov; 140(3):107652. PubMed ID: 37506513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extension of the molecular analysis to the promoter region of the iduronate 2-sulfatase gene reveals genomic alterations in mucopolysaccharidosis type II patients with normal coding sequence.
    Brusius-Facchin AC; Abrahão L; Schwartz IV; Lourenço CM; Santos ES; Zanetti A; Tomanin R; Scarpa M; Giugliani R; Leistner-Segal S
    Gene; 2013 Sep; 526(2):150-4. PubMed ID: 23707223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of iduronate -2- sulfatase gene in Tunisian patients with mucopolysaccharidosis type II.
    Chkioua L; Khedhiri S; Ferchichi S; Tcheng R; Chahed H; Froissart R; Vianey-Saban C; Laradi S; Miled A
    Diagn Pathol; 2011 May; 6():42. PubMed ID: 21605424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and genotypes of 201 patients with mucopolysaccharidosis type II in China: A retrospective, observational study.
    Zhong L; Gao X; Wang Y; Qiu W; Han L; Gu X; Zhang H
    Clin Genet; 2023 Jun; 103(6):655-662. PubMed ID: 36945845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Functional Characterization of
    Lin HY; Tu RY; Chern SR; Lo YT; Fran S; Wei FJ; Huang SF; Tsai SY; Chang YH; Lee CL; Lin SP; Chuang CK
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype-phenotype spectrum of 130 unrelated Indian families with Mucopolysaccharidosis type II.
    Agrawal N; Verma G; Saxena D; Kabra M; Gupta N; Mandal K; Moirangthem A; Sheth J; Puri RD; Bijarnia-Mahay S; Kapoor S; Danda S; H SV; Datar CA; Ranganath P; Shukla A; Dalal A; Srivastava P; Devi RR; Phadke SR
    Eur J Med Genet; 2022 Mar; 65(3):104447. PubMed ID: 35144014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mutational spectrum of hunter syndrome reveals correlation between biochemical and clinical profiles in Tunisian patients.
    Chkioua L; Grissa O; Leban N; Gribaa M; Boudabous H; Turkia HB; Ferchichi S; Tebib N; Laradi S
    BMC Med Genet; 2020 May; 21(1):111. PubMed ID: 32448126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of 11 novel mutations in 49 Korean patients with mucopolysaccharidosis type II.
    Sohn YB; Ki CS; Kim CH; Ko AR; Yook YJ; Lee SJ; Kim SJ; Park SW; Yeau S; Kwon EK; Han SJ; Choi EW; Lee SY; Kim JW; Jin DK
    Clin Genet; 2012 Feb; 81(2):185-90. PubMed ID: 21291454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype-phenotype correlation in 44 Czech, Slovak, Croatian and Serbian patients with mucopolysaccharidosis type II.
    Dvorakova L; Vlaskova H; Sarajlija A; Ramadza DP; Poupetova H; Hruba E; Hlavata A; Bzduch V; Peskova K; Storkanova G; Kecman B; Djordjevic M; Baric I; Fumic K; Barisic I; Reboun M; Kulhanek J; Zeman J; Magner M
    Clin Genet; 2017 May; 91(5):787-796. PubMed ID: 27883178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of 20 novel pathogenic variants in 60 unrelated Indian patients with mucopolysaccharidoses type I and type II.
    Uttarilli A; Ranganath P; Matta D; Md Nurul Jain J; Prasad K; Babu AS; Girisha KM; Verma IC; Phadke SR; Mandal K; Puri RD; Aggarwal S; Danda S; Sankar VH; Kapoor S; Bhat M; Gowrishankar K; Hasan AQ; Nair M; Nampoothiri S; Dalal A
    Clin Genet; 2016 Dec; 90(6):496-508. PubMed ID: 27146977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic analysis of 17 children with Hunter syndrome: identification and functional characterization of four novel mutations in the iduronate-2-sulfatase gene.
    Chistiakov DA; Kuzenkova LM; Savost'anov KV; Gevorkyan AK; Pushkov AA; Nikitin AG; Vashakmadze ND; Zhurkova NV; Podkletnova TV; Namazova-Baranova LS; Baranov AA
    J Genet Genomics; 2014 Apr; 41(4):197-203. PubMed ID: 24780617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Hunter syndrome (mucopolysaccharidosis type II) in Taiwanese: biochemical and linkage studies of the iduronate-2-sulfatase gene defects in MPS II patients and carriers.
    Lin SP; Chang JH; Lee-Chen GJ; Lin DS; Lin HY; Chuang CK
    Clin Chim Acta; 2006 Jul; 369(1):29-34. PubMed ID: 16480701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A molecular genetics view on Mucopolysaccharidosis Type II.
    Verma S; Pantoom S; Petters J; Pandey AK; Hermann A; Lukas J
    Mutat Res Rev Mutat Res; 2021; 788():108392. PubMed ID: 34893157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucopolysaccharidosis type II (Hunter syndrome): mutation "hot spots" in the iduronate-2-sulfatase gene.
    Rathmann M; Bunge S; Beck M; Kresse H; Tylki-Szymanska A; Gal A
    Am J Hum Genet; 1996 Dec; 59(6):1202-9. PubMed ID: 8940265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analysis of 63 Chinese patients with mucopolysaccharidosis type II: Functional characterization of seven novel IDS variants.
    Zhang W; Xie T; Sheng H; Shao Y; Lin Y; Jiang M; Xu A; Su X; Liu Z; Zhao X; Liu L; Huang Y
    Clin Chim Acta; 2019 Apr; 491():114-120. PubMed ID: 30639582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis of the iduronate-2-sulfatase gene in patients with mucopolysaccharidosis type II (Hunter syndrome).
    Bunge S; Steglich C; Beck M; Rosenkranz W; Schwinger E; Hopwood JJ; Gal A
    Hum Mol Genet; 1992 Aug; 1(5):335-9. PubMed ID: 1303211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucopolysaccharidosis type II: an update on mutation spectrum.
    Froissart R; Da Silva IM; Maire I
    Acta Paediatr; 2007 Apr; 96(455):71-7. PubMed ID: 17391447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype-phenotype relationship in mucopolysaccharidosis II: predictive power of IDS variants for the neuronopathic phenotype.
    Vollebregt AAM; Hoogeveen-Westerveld M; Kroos MA; Oussoren E; Plug I; Ruijter GJ; van der Ploeg AT; Pijnappel WWMP
    Dev Med Child Neurol; 2017 Oct; 59(10):1063-1070. PubMed ID: 28543354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.